Primary information |
---|
ID | 1131 |
Peptide Name | core peptide (CP) |
Sequence | GLRILLLKV |
Length | 9 |
Chirality | L |
N-terminal Modification | None |
C-terminal Modification | None |
Chemical Modification | None |
Linear/ Cyclic | Linear |
Nature | Protein Derived |
Source of Origin | T-cell antigen receptor alpha-chain transmembrane region |
Target | IL-2 |
Mechanism of Action | Inhibits IL-2 production |
In vitro/In vivo | In vitro |
Cell Line | Alanine scan, LK antigen-presenting cells |
Inhibition Concentartion | NA |
In vivo Model | NA |
Assay | Antigen presentation assay, CTLL assay |
Lethal Dose | NA |
Combination Therapy | NA |
Pubmed ID | 23066996 |
Year of Publication | 2013 |
3-D Structure | View in Jmol or Download Structure |